Patents Assigned to SUZHOU NEUPHARMA CO., LTD.
  • Certain chemical entities, compositions, and methods
    Patent number: 10912784
    Abstract: Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: February 9, 2021
    Assignee: SUZHOU NEUPHARMA CO., LTD.
    Inventor: Xiangping Qian
  • Beautyberry total glycosides extract and preparation method and use thereof
    Patent number: 10758585
    Abstract: Disclosed is a composition comprising an beautyberry total glycosides extract, and a method of preparation thereof, and the use of the composition thereof in preparing drugs for treating neurodegenerative diseases or skin diseases. The extract thereof is prepared from the leaves of Callicarpa cathayana H.T. Chang or Callicarpa formosana Rolfe, and contains 18% to 45% verbascoside and 15% to 40% Arenarioside.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: September 1, 2020
    Assignee: Suzhou Neupharma Co., Ltd.
    Inventors: Jingge Liu, Yijun Cheng, Jinguo Cao, Yongliang Zhu, Xiangping Qian
  • Certain chemical entities, compositions, and methods
    Patent number: 10471078
    Abstract: Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: November 12, 2019
    Assignee: Suzhou NeuPharma Co., Ltd.
    Inventor: Xiangping Qian
  • Certain chemical entities, compositions, and methods
    Patent number: 10179141
    Abstract: Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: January 15, 2019
    Assignee: SUZHOU NEUPHARMA CO., LTD.
    Inventor: Xiangping Qian
  • Certain chemical entities, compositions, and methods
    Patent number: 9814735
    Abstract: Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: November 14, 2017
    Assignee: SUZHOU NEUPHARMA CO., LTD
    Inventor: Xiangping Qian
  • Certain chemical entities, compositions, and methods
    Patent number: 9399659
    Abstract: Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: July 26, 2016
    Assignee: SUZHOU NEUPHARMA CO., LTD
    Inventor: Xiangping Qian
  • Tetradecahydro-1H-cyclopenta[a]phenanthrene compounds, compositions, and related methods of use
    Patent number: 9018197
    Abstract: Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: April 28, 2015
    Assignee: Suzhou Neupharma Co. Ltd.
    Inventor: Xiangping Qian
  • Certain chemical entities, compositions, and methods
    Patent number: 8993550
    Abstract: Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
    Type: Grant
    Filed: November 9, 2012
    Date of Patent: March 31, 2015
    Assignee: Suzhou Neupharma Co., Ltd.
    Inventor: Xiangping Qian
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
    Publication number: 20130123224
    Abstract: Chemical entities that are bufalin derivatives, pharmaceutical compositions and methods of treatment of cancer are described.
    Type: Application
    Filed: November 9, 2012
    Publication date: May 16, 2013
    Applicant: SUZHOU NEUPHARMA CO., LTD.
    Inventor: SUZHOU NEUPHARMA CO., LTD.